#602 Global Rank Marché Ouvert

Frederik Paulsen

Santé & Biotech. Health care.

Fortune Nette (Est.)

$6.8 B
+$433 (+0.00%) Aujourd'hui
Portefeuille : PolyPeptide Group ▲ High Growth
Frederik Paulsen

Photo: Press Agency / 2026

Profil Financier

Frederik Paulsen occupe actuellement le rang #602 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $6.8 B (+$433 sur 24h).

Frederick Paulsen inherited small drugmaker Ferring Pharmaceuticals, founded by his father in 1950.

When he took over running the business in 1983, it generated $15 million in annual revenue.

Today the biotech outfit, which makes infertility, obstetrics, urology, gastroenterology and endocrinology drugs, has estimated sales of $2.2 billion.

Ferring employs more than 6,500 people and has subsidiaries in nearly 60 countries.

Board members include H?l?ne Ploix, former director of the IMF, and Alexandra, the Countess of Frederiksborg, a former Danish princess.

Paulsen enjoys extreme adventure travel: he was the first person to cross the Bering Strait from Alaska to Russia in an ultralight aircraft.

Paulsen's father named the company Ferring after the name for inhabitants of F?hr, his native island off the coast of Germany.

Historique de Fortune (12 Mois)

1A 5A Max
Jan 25 Juin 25 Déc 25 Auj.

Répartition des Actifs

Actif / Société Parts Détenues Valeur Est. Tendance
PolyPeptide Group (PPGN-CH) 18.6M parts $989 M High Growth